JRI changes shareholder to accelerate its development and reinforce its leadership in wireless traceability and metrological monitoring solutions and metrology services. The management team, led by Pascal Vermeersch (a former manager and investor in small and medium-sized service companies), together with JRI's current management team (Eric Cartalas and André Grezel) and Turenne Santé, is leading the takeover of JRI, with a financing round that also includes Bpifrance and InnovaFonds.
The JRI Group designs and manufactures systems for monitoring various parameters (temperature, humidity, pressure, CO2...) to comply with legal traceability requirements in the healthcare and agri-food sectors. Its solutions are based on B-to-B connected objects, controlled by software installed on the customer's premises or in Saas mode, which carry out remote controls.
The JRI Group also offers its customers a full range of metrology services (calibration, mapping, qualification, etc.) and holds numerous Cofrac accreditations.
The development plan is based on an ambitious strategy that includes :
- Developing business with pharmaceutical companies;
- Deploying new transport solutions;
- Expanding the range of B-to-B connected objects and Saas solutions;
- Partnerships with specialized distributors to accelerate international growth.
Pascal Vermeersch, President of JRI, explains: " JRI is a solid company, a true French benchmark in monitoring and traceability in the healthcare and agri-food sectors. Thanks to our capacity for innovation and the support of our financial partners, we will be able to pursue our development and international expansion..
Eric Cartalas, JRI's Executive Vice President, Sales and Operations, comments: ". Our aim is to accelerate the development of our maintenance and metrology services, based on our understanding of our customers' needs, and to implement our Saas solutions in China, the USA, Latin America and the Middle East..
André Grezel, JRI's Technical and Quality Director, explains: " The arrival of new shareholders will enable us to accelerate our capacity to innovate in radio frequency, the Internet of Things and, of course, metrology, in order to maintain our technological leadership.
Mounia Chaoui, Associate Director of Turenne Santé, adds: "JRI is positioned at the crossroads of two fast-changing markets: healthcare and connected objects. There are many opportunities for growth, and we are confident in the management's ability to seize them. This transaction is fully in line with Turenne Santé's investment strategy, which aims to support the transfer of growing companies in the healthcare industry..
Cyril Chaumien, Director of Investments at Bpifrance, concludes: " We are delighted to support the transfer of a fine company, while giving it the means to continue innovating in its market, and to grow in France and internationally..
Learn more: www.jri.fr